Related Experiment Video
Updated: Nov 2, 2025

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay
Published on: June 16, 2023
Vasoactive Peptides: Role in COVID-19 Pathogenesis and Potential Use as Biomarkers and Therapeutic Targets
Pariya Khodabakhsh1, Afsaneh Asgari Taei2, Moein Mohseni3
1Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran; Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Insights
Vasoactive peptides are crucial for monitoring coronavirus disease 2019 (COVID-19) patients and can be therapeutic targets. Assessing these peptides aids in managing cardiovascular injuries associated with SARS-CoV-2 infection.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Pharmacology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes global health challenges, overwhelming healthcare systems.
- Beyond respiratory issues, COVID-19 patients frequently exhibit cardiovascular complications.
- Vasoactive peptides are key regulators in physiological and pathological processes.
Purpose of the Study:
- To review the role of specific vasoactive peptides in COVID-19.
- To explore their potential as therapeutic targets and prognostic biomarkers.
- To discuss peptides including Angiotensin II, VIP, ET-1, CGRP, natriuretic peptides, SP, and BK.
Main Methods:
- Literature review of existing studies on vasoactive peptides and COVID-19.
- Analysis of physiological and pathological roles of selected peptides.
- Synthesis of evidence regarding their clinical implications.
Main Results:
- Vasoactive peptides are implicated in the cardiovascular manifestations of COVID-19.
- These peptides show potential as indicators for disease severity and patient outcomes.
- Specific peptides may offer novel targets for therapeutic intervention.
Conclusions:
- Routine assessment of vasoactive peptides is recommended for COVID-19 patient monitoring.
- Vasoactive peptides represent promising therapeutic targets for managing COVID-19.
- Further research is needed to fully elucidate their clinical utility.
Background:
The ongoing outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as the latest threat to global health, causes overwhelming effects for the public healthcare systems worldwide. Of note, in addition to the respiratory complications, some patients with coronavirus disease 2019 (COVID-19) also develop serious cardiovascular injuries. Vasoactive peptides play an important role in a wide range of physiological and pathological conditions.
Aim:
With the urgent need for exploring the specific therapeutic targets and biomarkers for the emerging COVID-19, the general aim of this review is to discuss the potentials of the vasoactive peptides including Angiotensin II (Ang II), vasoactive intestinal peptide (VIP), endothelin-1 (ET-1), calcitonin gene-related peptide (CGRP), natriuretic peptides, substance P (SP) and bradykinin (BK) as therapeutic targets and/or prognostic indicators for the COVID-19 pandemic.
Conclusion:
Based on various observations some authors conclude that the assessment of vasoactive peptides shall be considered a routine part of COVID-19 patient monitoring, and they can serve as potential therapeutic targets for the disease management.
More Related Videos
07:53A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Published on: January 9, 2019
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Microorganisms in Medicine and Therapeutics
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...